These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6316232)

  • 1. [Cefotaxime and desacetylcefotaxime in cerebrospinal fluid of newborn and premature infants].
    von Loewenich V; Miething R; Uihlein M; Knothe H; Greipel-Zamorski M
    Padiatr Padol; 1983; 18(4):361-6. PubMed ID: 6316232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cerebrospinal fluid diffusion kinetics of cefotaxime and fosfomycin in Staphylococcus aureus meningitis with otorrhea].
    Tremeaux JC; Portier H; Sautreaux JL; Pechinot A; Kazmierczak A
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):556-8. PubMed ID: 6087251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefotaxime monotherapy in bacterial meningitis in childhood].
    Helwig H; Schlegel P
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):733-7. PubMed ID: 3796634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of childhood bacterial meningitis.
    Lecour H; Seara A; Cordeiro J; Miranda M
    Infection; 1989; 17(5):343-6. PubMed ID: 2689353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis.
    Bégué P; Floret D; Mallet E; Raynaud EJ; Safran C; Sarlangues J; Teyssier G
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():161-5. PubMed ID: 6094436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
    Goldwater PN
    Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
    Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
    Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
    Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.
    Asmar BI; Thirumoorthi MC; Buckley JA; Kobos DM; Dajani AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):138-40. PubMed ID: 4037772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.
    Friedland IR; Klugman KP
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1888-91. PubMed ID: 9303379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotaxime in treatment of meningitis and ventriculitis? Evaluation of drug concentrations in human cerebrospinal fluid.
    Brückner O; Collmann H; Hoffmann HG
    Intensive Care Med; 1982 Jan; 8(1):33-8. PubMed ID: 6276458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience.
    Jacobs RF; Kearns GL
    Diagn Microbiol Infect Dis; 1989; 12(1):93-9. PubMed ID: 2653717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of cefotaxime and fosfomycin in cerebrospinal fluid during the treatment of rabbit meningitis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Kazmierczak A; Pechinot A; Tremeaux JC; Duez JM; Kohli E; Portier H
    Infection; 1985; 13 Suppl 1():S76-80. PubMed ID: 3850855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotaxime pharmacokinetics and treatment of meningitis in neonates.
    Jacobs RF; Kearns GL
    Infection; 1989; 17(5):338-42. PubMed ID: 2689352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime therapy. Evaluation of its effect on bacterial meningitis, CSF drug levels, and bactericidal activity.
    Mullaney DT; John JF
    Arch Intern Med; 1983 Sep; 143(9):1705-8. PubMed ID: 6311128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime therapy of bacterial meningitis in children.
    Wells TG; Trang JM; Brown AL; Marmer BC; Jacobs RF
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():181-9. PubMed ID: 6094438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime levels in ventricular cerebrospinal fluid, determined by bioassay and by high-performance liquid chromatography.
    Brückner O; Collmann H; Borner K
    Chemotherapy; 1983; 29(4):237-43. PubMed ID: 6307602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of antimicrobial drugs in the cerebrospinal fluid.
    Skopnik H; Heimann G
    Pediatr Pharmacol (New York); 1983; 3(3-4):313-20. PubMed ID: 6330656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.